U.K. scrutinizes antipsychotic use

Add to a host of U.S. probes a new U.K. look at the use of antipsychotic drugs in dementia patients. British ministers have ordered a review of the meds, which have been linked to an increased risk of death in elderly patients with dementia, but continue to be used to pacify aggressive and disturbed patients. It's part of a new effort in the U.K. to codify dementia treatment, in anticipation of a huge increase in cases as the population ages.

- read the BBC report
- check out the story in The Guardian

Suggested Articles

Despite having lost some of its novelty, AZ's Brilinta is touting bleeding data over aspirin that could be a big break in acute coronary syndrome.

More than a year after J&J and Bayer pulled the plug on Xarelto in patients after a rare valve replacement, the pair are still seeking answers.

Having already whiffed on one crucial heart failure trial, Novartis is focusing on "profound" data from its Entresto studies in hopes for another go.